On May 16, 2022 SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, reported that it will host a virtual R&D Day for investors and analysts on Friday, June 10, 2022 at 10:00 am ET (Press release, SpringWorks Therapeutics, MAY 16, 2022, View Source [SID1234614711]). The program will include presentations by members of the SpringWorks executive leadership team as well as external thought leaders in the Company’s core development areas. A Q&A session will follow the presentations.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To register for SpringWorks’ virtual R&D Day, please sign up here. The webcast will also be available under "Events and Presentations" in the Investors & Media section of the SpringWorks website at View Source A replay of the webcast will be available on the Company’s website for a limited period of time following the event.